Danaher EBITDA Margin 2010-2022 | DHR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Danaher (DHR) over the last 10 years. The current EBITDA margin for Danaher as of June 30, 2022 is .
Danaher EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-06-30 $30.82B $10.13B 32.87%
2022-03-31 $30.28B $9.90B 32.69%
2021-12-31 $29.45B $9.69B 32.91%
2021-09-30 $28.07B $9.09B 32.38%
2021-06-30 $26.72B $9.01B 33.71%
2021-03-31 $24.80B $8.00B 32.24%
2020-12-31 $22.28B $6.46B 29.00%
2020-09-30 $20.39B $5.58B 27.34%
2020-06-30 $18.89B $4.85B 25.66%
2020-03-31 $18.03B $4.44B 24.61%
2019-12-31 $17.91B $4.46B 24.90%
2019-09-30 $15.56B $4.01B 25.79%
2019-06-30 $16.04B $4.09B 25.52%
2019-03-31 $16.57B $4.19B 25.25%
2018-12-31 $17.05B $4.23B 24.83%
2018-09-30 $16.80B $4.13B 24.60%
2018-06-30 $16.48B $4.05B 24.59%
2018-03-31 $16.01B $3.83B 23.93%
2017-12-31 $15.52B $3.69B 23.78%
2017-09-30 $17.83B $3.99B 22.40%
2017-06-30 $17.43B $3.90B 22.36%
2017-03-31 $17.16B $3.91B 22.76%
2016-12-31 $16.88B $3.86B 22.89%
2016-09-30 $13.57B $3.11B 22.93%
2016-06-30 $12.95B $2.75B 21.24%
2016-03-31 $13.66B $2.93B 21.47%
2015-12-31 $14.43B $3.04B 21.08%
2015-09-30 $18.58B $3.72B 20.01%
2015-06-30 $19.78B $4.17B 21.10%
2015-03-31 $19.78B $4.13B 20.87%
2014-12-31 $19.75B $4.15B 21.02%
2014-09-30 $19.60B $4.29B 21.87%
2014-06-30 $19.56B $4.25B 21.75%
2014-03-31 $19.34B $4.19B 21.68%
2013-12-31 $19.12B $4.13B 21.58%
2013-09-30 $18.83B $4.13B 21.95%
2013-06-30 $18.57B $4.06B 21.86%
2013-03-31 $18.39B $4.02B 21.84%
2012-12-31 $18.26B $4.01B 21.93%
2012-09-30 $18.00B $3.91B 21.69%
2012-06-30 $18.03B $3.79B 21.02%
2012-03-31 $17.12B $3.50B 20.45%
2011-12-31 $16.09B $3.25B 20.21%
2011-09-30 $14.61B $2.93B 20.05%
2011-06-30 $13.25B $2.73B 20.57%
2011-03-31 $12.83B $2.61B 20.35%
2010-12-31 $12.55B $2.44B 19.43%
2010-09-30 $11.78B $2.15B 18.24%
2010-06-30 $11.44B $2.05B 17.92%
2010-03-31 $10.90B $1.87B 17.11%
2009-12-31 $10.52B $1.77B 16.84%
Sector Industry Market Cap Revenue
Multi-Sector Conglomerates Diversified Operations $190.700B $29.453B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
General Electric (GE) United States $68.787B 24.99
3M (MMM) United States $63.967B 11.35
Carlisle (CSL) United States $14.504B 17.18
ITT (ITT) United States $5.442B 16.45
Federal Signal (FSS) United States $2.301B 21.69
Griffon (GFF) United States $1.677B 8.85
Vector Group (VGR) United States $1.385B 8.77
Lsb Industries (LXU) United States $1.264B 5.42
Steel Partners Holdings LP (SPLP) United States $0.882B 11.91
National Presto Industries (NPK) United States $0.455B 27.08
INNOVATE (VATE) United States $0.057B 0.00